Thyrocare Technologies (NSE:THYROCARE) EV-to-EBIT : 31.42 (As of May. 28, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Thyrocare Technologies's Enterprise Value is ₹31,475 Mil. Thyrocare Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,002 Mil. Therefore, Thyrocare Technologies's EV-to-EBIT for today is 31.42.

The historical rank and industry rank for Thyrocare Technologies's EV-to-EBIT or its related term are showing as below:

NSE:THYROCARE' s EV-to-EBIT Range Over the Past 10 Years
Min: 13.95 Med: 28.53 Max: 51.55
Current: 31.41

During the past 10 years, the highest EV-to-EBIT of Thyrocare Technologies was 51.55. The lowest was 13.95. And the median was 28.53.

NSE:THYROCARE's EV-to-EBIT is ranked worse than
69% of 100 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.44 vs NSE:THYROCARE: 31.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Thyrocare Technologies's Enterprise Value for the quarter that ended in Mar. 2024 was ₹29,872 Mil. Thyrocare Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,002 Mil. Thyrocare Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 3.35%.

Thyrocare Technologies EV-to-EBIT Historical Data

The historical data trend for Thyrocare Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies EV-to-EBIT Chart

Thyrocare Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-EBIT

Get a 7-Day Free Trial

17.97

30.41

17.31

23.74

29.82

Thyrocare Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															23.74	31.10	31.60	36.23	29.82

Competitive Comparison of Thyrocare Technologies's EV-to-EBIT

For the Diagnostics & Research subindustry, Thyrocare Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thyrocare Technologies's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's EV-to-EBIT falls into.

Thyrocare Technologies EV-to-EBIT Calculation

Thyrocare Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	31475.414	/	1001.9
	=	31.42

Thyrocare Technologies's current Enterprise Value is ₹31,475 Mil.
Thyrocare Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,002 Mil.

Thyrocare Technologies (NSE:THYROCARE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Thyrocare Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	1001.9	/	29871.609385
	=	3.35 %

Thyrocare Technologies's Enterprise Value for the quarter that ended in Mar. 2024 was ₹29,872 Mil.
Thyrocare Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,002 Mil.

Thyrocare Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Thyrocare Technologies (NSE:THYROCARE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

539871:India

Address

D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703

Website

https://www.thyrocare.com

Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies (NSE:THYROCARE) Headlines

No Headlines